Saranac Partners Ltd

Position in NVO — Novo Nordisk A S

CIK 2098745 LONDON, X0

Position in NVO

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$531,654

New position

Shares Held

11,090

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#693

of 1,348 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Saranac Partners Ltd holds $13,142,776 across 6 Drug Manufacturers - General names. NVO ranks #4 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	41,086	$10,338,881
2	AZN	Astrazeneca PLC	4,522	$857,461
3	LLY	ELI LILLY & Co	487	$584,122
4	NVO	Novo Nordisk A S This page	11,090	$531,654
5	BMY	Bristol Myers Squibb Co	7,311	$421,259
6	JNJ	Johnson & Johnson	1,612	$409,399

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$531,654	11,090	—	Shares	Sole	2026-08-13
No filing history on record for this holder in this stock.